Follow
Diane J. Burgess
Diane J. Burgess
University of Connecticut Board of Trustees Distinguished Professor of Pharmaceutics
Verified email at uconn.edu - Homepage
Title
Cited by
Cited by
Year
DNA-based therapeutics and DNA delivery systems: a comprehensive review
SD Patil, DG Rhodes, DJ Burgess
The AAPS journal 7, E61-E77, 2005
8192005
Biomaterials/tissue interactions: possible solutions to overcome foreign body response
JM Morais, F Papadimitrakopoulos, DJ Burgess
The AAPS journal 12, 188-196, 2010
6902010
Effect of acidic pH on PLGA microsphere degradation and release
BS Zolnik, DJ Burgess
Journal of Controlled Release 122 (3), 338-344, 2007
5792007
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms
M Siewert, J Dressman, CK Brown, VP Shah, JM Aiache, N Aoyagi, ...
Aaps Pharmscitech 4, 43-52, 2003
5562003
A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response
Y Onuki, U Bhardwaj, F Papadimitrakopoulos, DJ Burgess
Journal of diabetes science and technology 2 (6), 1003-1015, 2008
5002008
Implant coating for control of tissue/implant interactions
F Moussy, D Kreutzer, D Burgess, J Koberstein, F Papadimitrakopoulos, ...
US Patent 6,497,729, 2002
4502002
Implantable biosensor and methods of use thereof
F Jain, F Papadimitrakopoulos, D Burgess, DH Grantham
US Patent 8,914,090, 2014
4472014
Emerging synergy between nanotechnology and implantable biosensors: a review
S Vaddiraju, I Tomazos, DJ Burgess, FC Jain, F Papadimitrakopoulos
Biosensors and Bioelectronics 25 (7), 1553-1565, 2010
4172010
A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions
S Verma, R Gokhale, DJ Burgess
International journal of pharmaceutics 380 (1-2), 216-222, 2009
4042009
Technologies for continuous glucose monitoring: current problems and future promises
S Vaddiraju, DJ Burgess, I Tomazos, FC Jain, F Papadimitrakopoulos
Journal of diabetes science and technology 4 (6), 1540-1562, 2010
3602010
Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices
T Hickey, D Kreutzer, DJ Burgess, F Moussy
Biomaterials 23 (7), 1649-1656, 2002
3492002
Influence of interfacial properties of lipophilic surfactants on water-in-oil emulsion stability
FO Opawale, DJ Burgess
Journal of colloid and interface science 197 (1), 142-150, 1998
3341998
Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening
S Verma, S Kumar, R Gokhale, DJ Burgess
International journal of pharmaceutics 406 (1-2), 145-152, 2011
3262011
Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres
BS Zolnik, DJ Burgess
Journal of Controlled Release 127 (2), 137-145, 2008
3262008
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis
SD Patil, F Papadmitrakopoulos, DJ Burgess
Journal of controlled release 117 (1), 68-79, 2007
2832007
Practical analysis of complex coacervate systems
DJ Burgess
Journal of colloid and interface science 140 (1), 227-238, 1990
2831990
Elevated temperature accelerated release testing of PLGA microspheres
BS Zolnik, PE Leary, DJ Burgess
Journal of Controlled Release 112 (3), 293-300, 2006
2812006
Rheology and stability of water-in-oil-in-water multiple emulsions containing Span 83 and Tween 80
J Jiao, DJ Burgess
Aaps Pharmsci 5, 62-73, 2003
2722003
Quality by design approach to understand the process of nanosuspension preparation
S Verma, Y Lan, R Gokhale, DJ Burgess
International journal of pharmaceutics 377 (1-2), 185-198, 2009
2502009
In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices
T Hickey, D Kreutzer, DJ Burgess, F Moussy
Journal of Biomedical Materials Research: An Official Journal of The Society …, 2002
2272002
The system can't perform the operation now. Try again later.
Articles 1–20